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Abstract
Background: Yawning consistently poses a conundrum to the medical profession and neuroscientists. Despite neurological
evidence such as parakinesia brachialis oscitans in stroke patients and thermo-irregulation in multiple sclerosis patients, there is
considerable debate over the reasons for yawning with the mechanisms and hormonal pathways still not fully understood. Cortisol
is implicated during yawning and may link many neurological disorders. Evidence was found in support of the Thompson cortisol
hypothesis that proposes cortisol levels are elevated during yawning just as they tend to rise during stress and fatigue.
Objectives: To investigate whether saliva cortisol levels rise during yawning and, therefore, support the Thompson cortisol
hypothesis.
Methods: We exposed 20 male and female volunteers aged between 18 and 53 years to conditions that provoked a yawning
response in a randomized controlled trial. Saliva samples were collected at the start and again after the yawning response, or at
the end of the stimuli presentations if the participant did not yawn. In addition, we collected electromyographic data of the jaw
muscles to determine rest and yawning phases of neural activity. Yawning susceptibility scale, Hospital Anxiety and Depression
Scale, General Health Questionnaire, and demographic and health details were also collected from each participant. A comprehensive
data set allowed comparison between yawners and nonyawners, as well as between rest and yawning phases. Collecting
electromyographic data from the yawning phase is novel, and we hope this will provide new information about neuromuscular
activity related to cortisol levels. Exclusion criteria included chronic fatigue, diabetes, fibromyalgia, heart conditions, high blood
pressure, hormone replacement therapy, multiple sclerosis, and stroke. We compared data between and within participants.
Results: In the yawning group, there was a significant difference between saliva cortisol samples (t10 = –3.071, P = .01). Power
and effect size were computed based on repeated-measures t tests for both the yawning and nonyawning groups. There was a
medium effect size for the nonyawners group (r = .467) but low power (36%). Results were similar for the yawners group: medium
effect size (r = .440) and low power (33%).
Conclusions: There was significant evidence in support of the Thompson cortisol hypothesis that suggests cortisol levels are
elevated during yawning. A further longitudinal study is planned to test neurological patients. We intend to devise a diagnostic
tool based on changes in cortisol levels that may assist in the early diagnosis of neurological disorders based on the data collected.
Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN): 61942768;
http://www.controlled-trials.com/ISRCTN61942768/61942768 (Archived by WebCite at http://www.webcitation.org/6A75ZNYvr)
(Interact J Med Res 2012;1(5):e4)   doi:10.2196/ijmr.2241
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Introduction
Yawning consistently poses a conundrum to neurologists and
neuroscientists [1]. Increasingly, evidence is found to link
neurological disorders through the commonality of yawning
episodes and contagious yawning. Despite discrete incidences
(such as parakinesia brachialis oscitans) in brain stem ischemic
stroke patients, there is considerable debate over the reasons
for yawning, with the mechanism of yawning still not fully
understood [2]. Cortisol is implicated during yawning and may
link many neurological disorders. Evidence was found in support
of the Thompson cortisol hypothesis [3,4] that proposes cortisol
levels are elevated during yawning just as cortisol levels are
known to be raised in instances of stress and fatigue [5].
There have been several explanations about the yawning
mechanism. Yawning is a physiological behavior that has been
described as a transition between wakefulness and sleep [6].
According to Walusinski [7], yawns exteriorize the activity of
the motor centers of the brain stem (cranial nerves V, VII, IX,
X, XI, and XII) and of the spinal cord under the control of the
hypothalamic paraventricular nucleus. The hypothalamic
paraventricular nucleus is a point of integration between the
central and peripheral autonomic systems. Walusinski [7]
comprehensively presents several disorders due to deregulation
of yawning:
• anhedonia (frustration because of an incomplete or
inharmonious development of a yawn possibly due to
unconscious inhibition of the letting go that underlies a
complete yawn)
• the disappearance of a yawn (indicating the activity state
of the dopaminergic neurons of the hypothalamic
paraventricular nucleus, which are necessary for yawning)
• excessive yawning (possibly linked to hunger and arousal)
and famously illustrated in Charcot’s Leçons du Mardi de
la Salpêtrière [8] by his patient who yawned eight times in
a minute.
Yawning is a powerful reflex that may serve to evacuate the
palatine tonsillar fossae [9]. This is a possible explanation
because the strong reflex does not have any immediate urgency,
is reflected in our circadian rhythm, and is allocated to times
that cause us minimal inconvenience. However, McKenzie [9]
suggests that, due to our social sanctions in the Western world
to generally suppress the yawning reflex, perhaps we are leading
to endemic tonsillitis.
Spontaneous yawning is present in humans from the early stages
of development [10]. It has been observed in infants and
newborns and in fetuses of 12- to 14-weeks’ gestational age.
The time course of yawning seems to differ with age [6], with
adults yawning in the early morning and late evening [11]; in
young adults, yawning seems to be linked to a low level of
vigilance, increasing before and after the sleep episode [12].
Yawning is also contagious and can be elicited by seeing or
even hearing someone else yawn [13]. Yet yawning has also
been observed in other species [14,15], which has led to
suggestions that yawning may serve communicative as well as
physiological functions.
Some authors do believe that the physiological explanations
given by some researchers do not adequately explain the reasons
why we yawn. For example, Guggisberg and colleagues [16]
argue that research tends to support yawning as a communicative
function. Gallup [17] suggests it is likely that there is not just
one theory to explain the functions of yawning, and it is unlikely
that yawning serves primarily as a communicative function,
since experimental evidence of contagious yawning is observed
in only a small number of species in one lineage (primates). We
tend to agree with this notion and believe the evidence of
yawning in patients with neurological disorders and stroke (such
as parakinesia brachialis oscitans) tends to suggest that there
are specific mechanisms for yawning that are excited under
special circumstances. However, it is acknowledged that
yawning may be elicited because of empathy in Homo sapiens
[18,19].
The debate for clarity continues [20]. Some authors argue that
physiological explanations are imprecise and that there is
evidence that neural networks responsible for empathy and
social skills may be implicated and activated during the yawning
episode. There is a problem with comparing some studies due
to methodological differences and inadequacies [21].
However, evidence from neurological patients has led to a new
line of enquiry that focuses on thermoregulation. Corey and
colleagues [22] examined physiological measurements taken
before, during, and after yawns in humans. They concluded
their data are most consistent with the brain-cooling hypothesis
and advocate that yawning increases blood flow. Indeed, it is
known that painful headaches [23] and thermoregulatory
disorders [24] may arise from excessive yawning. Corey and
colleagues [22] suggest that the yawning experienced during
these times may be due to circulatory dysfunction.
Gallup and Gallup [25] reported on repetitive yawning in
patients with multiple sclerosis, showing that thermoregulatory
dysfunction is a symptom of multiple sclerosis. Furthermore,
yawning seems to provide symptom relief in patients with
multiple sclerosis. Gallup and Eldakar [26] also showed that
the incidence of yawning in humans is associated with seasonal
climate variation.
Researchers are constantly striving to find commonality in
disorders via their metabolic or neuronal pathways. It is
interesting to note in past years how the treatment of Parkinson
disease could be modified because of the exploration of
dopaminergic and serotonic pathways [1,27,28]. Uncertainty
in the functions of some neurotransmitters and their possible
multiple implications in chemical pathways presents a
complicated picture that is not unlike the clinical signature of
Alzheimer disease in those with comorbid Down syndrome
[29]. Having Alzheimer disease together with Down syndrome
does not necessarily result in the clinical symptoms of dementia
in later life [30].
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The overlap between symptoms and neurochemical pathways
may be more apparent than initially thought. New evidence has
emerged of overlapping pathways involving DISC1, a scaffold
protein that interacts with multiple neurodevelopmental,
cytoskeletal, and signaling proteins [31], and Huntingdon disease
[32]. In time, it is hoped that yawning and its role in neurological
disorders may be understood by exploring its presence as a
symptom in different neurological disorders.
Indeed, Collins and Eguibar [33] stated that antagonist
interaction studies have now clearly defined at least 3 distinct
neural pathways involved in the induction of yawning. Scientists
are beginning to understand the hierarchical order through which
these different neurotransmitter systems interact to regulate
yawning. So far, the following neurotransmitters and
neurohormones have been implicated: acetylcholine, dopamine,
glutamate, serotonin, oxytocin, gamma-aminobutyric acid,
opioids, adrenergics, nitric oxide, adrenocorticotropic hormone,
and alpha-melanocyte stimulating hormone. Yet advanced
techniques, such as functional magnetic resonance imaging, are
yet to yield conclusive evidence to assist in fully explaining the
yawn [34].
Yawning has often been associated with fatigue, stress, and
exposure to cold [1]. During exposure to cold, the cortisol level
in humans rises dramatically, except when they are exposed
quickly (as in the cold face test), when there are reduced cortisol
rises, perhaps due to vagal inhibition [35]. It is suspected that
exposure to extreme cold temperature gives rise to a similar
stress-like response with respect to cortisol levels in humans.
Cortisol is known to be present and elevated during stressful
situations. Blood cortisol levels are directly related to salivary
cortisol levels [36], which have been documented in various
paradigms. The cortisol level and stress correlation is
curvilinear. However, in preterm infants, cortisol levels may be
lower during the heel-stick pain procedure [37], and in girls
whose parents had depressive problems, cortisol levels were
blunted [38]. In animal models, the cortisol level profile is also
similar to that in humans during stressful situations [39]. Cortisol
levels appear higher after being subjected to stress-induced
situations [40].
What is unknown is the cortisol level during yawning. The
cortisol level may be higher when yawning occurs after exposure
to cold than after exposure to a stressful situation. Are cortisol
levels elevated when neurologically impaired patients yawn,
perhaps in those with multiple sclerosis?
The link between fatigue and hormonal changes is well
documented. A greater level of neuromuscular fatigue and larger
responses in serum hormone concentrations have been seen, for
example, after hypertrophic variable resistance loadings [41].
This has led to identifying markers of fatigue [42], particularly
following postmatch professional rugby [43] and in young
athletes [44]. Elevated salivary cortisol levels have also been
seen in elite tennis players [45]. Sleep deprivation and fatigue
have been linked with salivary cortisol levels; in this instance,
cortisol levels are lowered [46].
Cortisol is a lipophilic steroid with low molecular weight.
Following binding with adrenocorticotropic hormone to
membrane receptors and cells of the adrenal cortex, cortisol is
then synthesized and released into the blood stream. Since most
(about 95%) is bound to large proteins, such as albumin, only
the small fraction of unbound free cortisol is thought to be
biologically active and enters cells by passive diffusion. This
makes it feasible to measure the free cortisol fraction in all
bodily fluids, for example, saliva [47].
Levels of  cort isol  are regulated by the
hypothalamic-pituitary-adrenal axis, which is a complex set of
interactions between the hypothalamus (known to regulate body
temperature) and the pituitary and adrenal glands. The
hypothalamic-pituitary-adrenal axis also assists in digestion,
the immune system, sexuality, mood, and energy usage [48]. It
is implicated in stress, trauma, and particular disorders such as
fibromyalgia and chronic fatigue syndrome.
Curiously, the compound glycyrrhizic acid, found in licorice,
has been found to increase the activity of cortisol in the kidney
[49]. This is thought to be due to inhibition of the enzyme
11 -hydroxysteroid dehydrogenase type 2, which normally
inactivates cortisol in the kidney; hence, licorice tends to inhibit
this enzyme and in turn deregulates, resulting in an increase of,
cortisol levels. Anecdotally, we asked 1 of our study participants
to eat licorice after providing a saliva sample and observed a
rise in cortisol levels. This would need to be investigated further
to discern significance in this finding.
Methods
We recruited 20 male and female volunteers aged between 18
and 53 years from students at Bournemouth University, Poole,
UK, using a computerized recruitment system (Sona Systems,
Tallinn, Estonia) and Facebook. Consent from all participants
was properly obtained according to code of conduct and research
guidelines. Participants were exposed, under randomized
controlled trials guidelines, to three conditions intended to
provoke a yawning response: photos of people yawning; boring
text about yawning; and a short video of a person yawning.
Comparisons were made with people exposed to the same
conditions but who did not yawn.
We collected saliva samples at the start and again after a
yawning response, together with electromyographic data of the
jaw muscles via surface-placed electrodes to determine rest and
yawning phases of neural activity. If there was no yawning
response, then we took a second saliva sample at the end of the
experimental paradigm. A yawning susceptibility scale
(questionnaire designed for this study), Hospital Anxiety and
Depression Scale (HADS) [48,50], General Health
Questionnaire-28 (GHQ-28) [51-56], and demographic and
health details were also collected from each participant.
Exclusion criteria were chronic fatigue, diabetes, fibromyalgia,
a heart condition, high blood pressure, hormone replacement
therapy, multiples sclerosis, and stroke. Between- and
within-participant comparisons were made using t tests, and
correlations were calculated using the SPSS package, version
19 (IBM Corporation, Somers, NY, USA). This enabled a
comparison to be made between yawner and nonyawner
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participants, as well as between rest status and yawning
episodes.
Ethics
Bournemouth University research and ethics approval was
granted (BU-PS5/10/11; PS1/3/12). Professional code of
conduct, confidentiality, and safety issues were addressed and
approved in the ethics submission. Data collected were made
anonymous, coded, securely stored, and destroyed after
completion of the study analysis. Protective measures were put
in place for collection and analysis of saliva samples, and the
right of participants to withdraw from the study was made clear
to all participants.
Funding
This research received funding of £4000 from the host
institution, Bournemouth University to support the purchase of
essential equipment and materials. In addition, £4344 was
received from Santander plc for travel expenses incurred to
assist the first author to gain essential information for the
selection and analysis of salivary cortisol kits.
Results
In saliva cortisol sample 1, the mean for nonyawners (n=9) was
3.3889 (SD 1.43479) and for yawners (n=11) was 2.9727 (SD
1.94889). In sample 2, the means were 4.5778 (SD 1.93589)
for nonyawners and 3.9273 (SD 2.36309) for the yawners (Table
1).
There were no significant differences between groups in terms
of age (t18 = –0.071, P = .94), HADS depression scores (t18 =
0.890, P = .39), GHQ-28 scores (t18 = 0.663, P = .52), or HADS
anxiety scores (t18 = 0.484, P = .63). Age, depression, GHQ-28
total, and anxiety scores were not significantly correlated with
sample 1 (saliva cortisol) (Table 2).
Table 1. Descriptive statistics of participants.
nSDMeanYawn
Sample 1
91.434793.3889Nonyawn
111.948892.9727Yawn
201.706153.1600Total
Sample 2
92.935894.5778Nonyawn
112.363093.9273Yawn
202.584284.2200Total
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Table 2. Correlations between independent variables (n = 20) for sample 1.
Sample 1DepressionAnxietyGeneral
total
AgeVariable
Age
.093–.582a–.709a–.4281Pearson correlation
.70.01.0.06P value (2-tailed)
General total
–.185.790a.4251–.428Pearson correlation
.44.0.06.06P value (2-tailed)
Anxiety
–.011.750a1.425–.709aPearson correlation
.96.0.06.0P value (2-tailed)
Depression
–.0051.750a.790a–.582aPearson correlation
.98.0.0.01P value (2-tailed)
Sample 1
1–.005–.011–.185.093Pearson correlation
.98.98.44.70P value (2-tailed)
a Correlation is significant at the 0.01 level (2-tailed).
Results were normally distributed, as illustrated by the
Shapiro-Wilk analysis (Table 3). Results for sample 1 (saliva
cortisol taken at the start) suggest that there were no significant
differences between those who yawned and those who did not,
as confirmed by an independent-samples t test (t18 = 0.532, P
= .60). An independent-samples t test suggests that there were
no significant differences in sample 2 (saliva cortisol taken
either after yawning or after the last stimuli presentation if the
participant did not yawn) between those who yawned and those
who did not (t18 = 0.550, P = .59).
Table 3. Normality testing of data.
Shapiro-WilkKolmogorov-Smirnova
Sample P valuedfStatisticP valuedfStatistic
Sample 1
.289.901.20b9.199Nonyawn
.3111.919.1511.218Yawn
Sample 2
.059.836.179.234Nonyawn
.5111.939.20b11.152Yawn
a Lilliefors significance correction.
b This is a lower bound of the true significance.
There were no significant differences in saliva cortisol between
sample 1 and sample 2 for those who did not yawn during the
experiment. This was confirmed using a repeated-measures t
test (t8 = –1.710, P = .13; Table 4).
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Table 4. Paired-samples test for nonyawners and yawners (sample 1 – sample 2).
P value
(2-tailed)dft Test
95% CIa of
the differenceSEMSDMeanStudy group
.138–1.710–2.79182 to
.41404
.995112.08533–1.18889Nonyawners
.0110–3.071–1.64710 to
–.26199
.310821.03089–.95455Yawners
a Confidence interval.
However, there was a significant difference in saliva cortisol
between sample 1 and sample 2 among the yawners (t10 =
–3.071, P = .01; Table 4).
Power and Effect Size
We computed power and effect size based on repeated-measures
t tests for both the yawning and nonyawning groups. There was
a medium effect size for the nonyawners (r = .467) but low
power (36%). Results were similar for the yawners: medium
effect size (r = .440) and low power (33%).
Saliva Cortisol Samples
Correlations between participants’ HADS anxiety scores and
sample 1 (saliva cortisol) were not significant (r = –.11, n = 20,
P = 0.96); nor were correlations between participants’ HADS
depression scores and sample 1 (saliva cortisol; r = –.005, n =
20, P = .98).
Correlations between participants’ GHQ-28 total score and
sample 1 (saliva cortisol) were not significant (r = –.185, n =
20, P = .44); nor were correlations between age and sample 1
(saliva cortisol; r = .93, n = 20, P = .70).
Therefore, it was unnecessary to run an analysis of covariance,
as none of the covariates were sufficiently correlated.
Normal Distribution Test
Sample 1 (saliva cortisol) was normally distributed across the
whole group of participants (W (20) = 0.939, P = .23). It was
normally distributed for the nonyawners (W (9) = 0.901, P =
.26) and for the yawners (W (110) = 0.919, P = .31).
Sample 2 (saliva cortisol) was normally distributed (W (200)
= 0.929, P = .15) across the whole group. It was normally
distributed for the nonyawners (W (90) = 0.836, P = .53) and
for the yawners (W (110) = .0939, P = .51).
t Tests: Between Groups
For the yawners versus nonyawners, there was no significant
difference between the groups for sample 1 (saliva cortisol; t180
= 0.532, P = .60) or for sample 2 (saliva cortisol; t18 = 0.550, P
= .59).
t Tests: Within Groups
There was no significant difference between sample 1 (saliva
cortisol) and sample 2 (saliva cortisol) in the nonyawning group
(t8 = –1.710, P = .13). However, in the yawning group, there
was a significant difference between samples (t10 = –3.071, P
= .01).
Discussion
Several interesting findings have emerged from the study, which
are consistent with the original hypothesis. Among those who
yawned, there was a significant difference in cortisol levels
between sample 1 and sample 2. A t test confirmed that there
were no significant differences in salivary cortisol levels
between those who yawned and those who did not for the first
baseline sample (sample 1). Furthermore, there were no
significant differences in a repeated-measures t test between
sample 1 and sample 2 for those who did not yawn.
It was a concern while designing the study that age, recent
anxiety and depression levels, and general health could all
potentially be factors affecting participants’ baseline cortisol
levels. If this were the case, these factors could also have
contributed toward the change in cortisol levels, and the
experiment could have been measuring interference from these,
rather than a change due to the independent variable (whether
or not participants yawned during the experiment). However,
correlation analysis suggested that these did not play a
significant part in cortisol levels, with nonsignificant correlations
across all variables. There were no significant differences in
baseline cortisol levels between those who yawned and those
who did not.
Age, recent anxiety and depression levels, or general health
could also have had a potential impact on cortisol levels, which
could have affected whether a participant yawned or not during
the study. The t tests for each of the above variables confirmed
that there were no significant differences in these factors
between groups.
Although we used a relatively low sample size, inspection of
data (Table 3) suggests that the differences between groups in
terms of cortisol change between sample 1 and 2 were not vast.
We intend to investigate these findings further by conducting
the experiment on a larger scale, with a proposed 100
participants. Calculation using G*Power suggests that for a
power size of 80%, 27 participants will be required for each
group; therefore, 100 participants should permit random
allocation of 50 participants per group. Investigation of
participants with different neurological disorders, such as
multiple sclerosis, is also planned. We hope to achieve an
understanding of yawning and its role in neurological disorders,
together with the potential development of a diagnostic test for
the early identification of neurological sequelae.
As well as being of interest to clinical scientists and
practitioners, yawning is clearly of interest in the media. A
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newspaper article has cited interest by the US Department of
Homeland Security, which warned that apparently innocuous
yawning behavior in passengers could signal a would-be terrorist
[57]. Although this reported observation can be argued as
perhaps being rather tangential to the pursuit of an explanation
of yawning, this tends to highlight the importance of other
contributing factors such as the social milieu and cultural norms.
Social and physiological factors as well as cortisol activity are
all important considerations, not only because they may
potentially provide the answer to why we yawn but also because
they may help in the development of a potential diagnostic test.
The research team led by the first author at Bournemouth
University is interested in determining whether we are truly
born to yawn as a protective indicator of untoward neurological
dysfunction. Yawning is perhaps a warning, neurologically
speaking.
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